vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
36.00
+1.33 (3.84%)
At close: Mar 4, 2026, 4:00 PM EST
35.28
-0.72 (-2.00%)
After-hours: Mar 4, 2026, 5:38 PM EST
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $446.72 million as of March 4, 2026. Its market cap has increased by 363.00% in one year.
Market Cap
446.72M
Enterprise Value
348.58M
1-Year Change
363.00%
Ranking
Category
Stock Price
$36.00
Market Cap Chart
Since July 31, 2015, vTv Therapeutics's market cap has increased from $78.12M to $446.72M, an increase of 471.80%. That is a compound annual growth rate of 17.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 446.71M | -9.98% |
| Dec 31, 2025 | 496.22M | 445.90% |
| Dec 31, 2024 | 90.90M | 288.02% |
| Dec 29, 2023 | 23.43M | -56.62% |
| Dec 30, 2022 | 54.01M | -18.92% |
| Dec 31, 2021 | 66.61M | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PepGen | 464.74M |
| Anavex Life Sciences | 463.36M |
| REGENXBIO | 462.70M |
| 4D Molecular Therapeutics | 455.50M |
| Immix Biopharma | 451.07M |
| Entrada Therapeutics | 450.00M |
| Verastem | 448.43M |
| Enanta Pharmaceuticals | 447.19M |